Does COVID-19 predispose patients to cancer? A peek behind the paper with Priya Hays

Written by Priya Hays (Talis Biomedical, CA, USA)

Take a peek behind the latest article published by Future Oncology with lead author, Priya Hays (Talis Biomedical, CA, USA). Hays is a technical writer for molecular diagnostics and author of several publications on healthcare, including personalized medicine and cancer immunotherapies. She is the author of several publications, including her third book on ‘Advancing Healthcare Through Personalized Medicine’. In this interview, Hays discusses her hypothesis that COVID-19 may predispose patients to cancer, and the impact this may have on screening strategies. Want regular updates straight to your inbox? Become a member of Oncology Central.   Could you briefly outline your recent...

To view this content, please register now for access

It's completely free